Device and method for reducing cardiac valve regurgitation

Abstract

A catheter (4) based medical system (1) and medical procedure for reducing cardiac valve regurgitation are disclosed. The system comprises a resilient curvilinear shaped annuloplasty implant (3) for reducing the size of a dilated annulus (18) of said valve for reducing said regurgitation having resilient anchoring elements (300), and a delivery device (2) for said annuloplasty implant (3) having a distal curvilinear shaped portion (200) that is hollow to mount said annuloplasty implant (3) and has an annular opening (201) arranged to be in apposition against an annulus (18) of said cardiac valve. The annuloplasty implant (3) is arranged to be releasable in said hollow and has said resilient anchoring elements (300) arranged in a restrained spring loaded delivery conformation in said hollow, and wherein said resilient anchoring elements (300) when released are arranged in a tissue engaging conformation protruding out of said opening.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This application is a divisional of copending U.S. utility application entitled, “Device And Method For Reducing Cardiac Valve Regurgitation,” having Ser. No. 13 / 575,539, filed Aug. 27, 2012, which is a 35 U.S.C. §371 national stage of, and claims priority to and the benefit of, PCT application No. PCT / EP2011 / 051177, entitled, “Device and Method for Reducing Cardiac Valve Regurgitation”, filed on Jan. 27, 2011. This application also claims priority to and benefit of European Patent Application No. 10151853.8, filed on Jan. 27, 2010, which is entirely incorporated herein by reference.FIELD OF THE INVENTION[0002]This invention pertains in general to the field of medical devices and methods. More particularly the invention relates to cardiac valve repair devices and methods, and even more particularly to a system of mitral valve annuloplasty rings and corresponding delivery tools for said rings, as well as associated methods and procedures.BA...

AI Technical Summary

Benefits of technology

This patent describes a medical device that can be used to reduce regurgitation in cardiac valves. The device is made of a curved implant that is designed to fit tightly around the valve to prevent leaks. The implant has special elements that can be compressed and then released to secure the device in place. This invention provides a more effective way to treat heart valve regurgitation.

Problems solved by technology

One common example of valvular dysfunction occurs, when the annulus becomes excessively dilated or the valve geometry results in ineffective valve closure, which results in regurgitation.

Due to the increased diameter of the annulus, the leaflets or cusps fail to meet during systolic contraction, thereby resulting in the regurgitation of blood during ventricular contractions.

After deployment, the device is not retrievable from the patient other than by open chest surgery.

This may be a major disadvantage when the device is malpositioned.

This also means that the maximum anchoring depth of the anchor when released is limited.

Moreover, the annuloplasty ring may not comprise a collar element around the ring, sometimes desired to improve sealing of the ring against the annulus, as the anchors would be hindered from their movement.

After deployment, the device is not retrievable from the patient other than by open chest surgery.

This may be a major disadvantage when the device is malpositioned.

Images